Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There has been recent interest in the possible role of reperfusion-induced inflammation with neuronal injury after stroke. Enlimomab, a murine intercellular adhesion molecule-1 (ICAM-1) antibody, reduces leukocyte adhesion and infarct size in experimental stroke studies. The purpose of the current clinical trial was to evaluate the use of enlimomab after ischemic stroke. METHODS: A total of 625 patients with ischemic stroke were randomized to receive either enlimomab (n = 317) or placebo (n = 308) within 6 hours of stroke onset. Treatment was given over 5 days. Patients were evaluated at baseline and on days 5 and 90 after initiation of treatment; long-term assessments were carried out after 6 and 12 months. The primary efficacy endpoint was the response to therapy at 90 days on the Modified Rankin Scale; other endpoints included Barthel Index (BI) and NIH Stroke Scale and survival. RESULTS: At day 90, the Modified Rankin Scale score was worse in patients treated with enlimomab than with placebo (p = 0.004). Fewer patients had symptom-free recovery on enlimomab than placebo (p = 0.004), and more died (22.2 versus 16.2%). The negative effect of enlimomab was apparent on days 5, 30, and 90 of treatment (p = 0.005). There were significantly more adverse events with enlimomab treatment than placebo, primarily infections and fever. Patients experiencing fever were more likely to have a poor outcome or die. CONCLUSIONS: The authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for ischemic stroke in the model studied and, indeed, may significantly worsen stroke outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Mahoney, F. I., & Barthel, D. W. (2013) · PsycTESTS Dataset · doi:10.1037/t02366-000 · Cited by 887
del Zoppo, G. J., Schmid-Schönbein, G. W., Mori, E., Copeland, B. R., & Chang, C. M. (1991) · Stroke · doi:10.1161/01.str.22.10.1276 · Cited by 765
Kochanek, P. M., & Hallenbeck, J. M. (1992) · Stroke · doi:10.1161/01.str.23.9.1367 · Cited by 615
Smith, C. W., Rothlein, R., Hughes, B. J., Mariscalco, M. M., Rudloff, H. E., Schmalstieg, F. C., & Anderson, D. C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113788 · Cited by 599
Leucocyte-endothelial interactions and regulation of leucocyte migration
Adams, D. H., & Shaw, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92029-x · Cited by 575
Brain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals
Chan, P. H., Schmidley, J. W., Fishman, R. A., & Longar, S. M. (1984) · Neurology · doi:10.1212/wnl.34.3.315 · Cited by 382
Zhang, R. L., Chopp, M., Li, Y., Zaloga, C., Jiang, N., Jones, M. L., Miyasaka, M., & Ward, P. A. (1994) · Neurology · doi:10.1212/wnl.44.9.1747 · Cited by 362
Zhang, R. L., Chopp, M., Jiang, N., Tang, W. X., Prostak, J., Manning, A. M., & Anderson, D. C. (1995) · Stroke · doi:10.1161/01.str.26.8.1438 · Cited by 351
Endothelial ICAM-1 Expression Associated With Inflammatory Cell Response in Human Ischemic Stroke
Lindsberg, P. J., Carpe´n, O., Paetau, A., Karjalainen-Lindsberg, M.-L., & Kaste, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.939 · Cited by 275
Evangelista, V, Manarini, S., Rotondo, S., Martelli, N., Polischuk, R., McGregor, J., de Gaetano, G., & Cerletti, C. (1996) · Blood · doi:10.1182/blood.v88.11.4183.4183 · Cited by 238
Clark, W. M., Madden, K. P., Rothlein, R., & Zivin, J. A. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.75.4.0623 · Cited by 210
The role of inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy
DeGraba, T. J. (1998) · Neurology · doi:10.1212/wnl.51.3_suppl_3.s62 · Cited by 205
Bowes, M. P., Rothlein, R., Fagan, S. C., & Zivin, J. A. (1995) · Neurology · doi:10.1212/wnl.45.4.815 · Cited by 196
SCHOETTLE, R. J., KOCHANEK, P. M., MAGARGEE, M. J., UHL, M. W., & NEMOTO, E. M. (1990) · Journal of Neurotrauma · doi:10.1089/neu.1990.7.207 · Cited by 196
Zanette, E. M., Roberti, C., Mancini, G. B. J., Pozzilli, C., Bragoni, M., & Toni, D. (1995) · Stroke · doi:10.1161/01.str.26.3.430 · Cited by 122
Schneider, D., Berrouschot, J., Brandt, T., Hacke, W., Ferbert, A., Norris, S. H., Polmar, S. H., & Schäfer, E. (1998) · European Neurology · doi:10.1159/000007962 · Cited by 76
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells
Jin, R., Yang, G., & Li, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1109766 · Cited by 1,521
The inflammatory response in stroke
Wang, Q., Tang, X. N., & Yenari, M. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.014 · Cited by 1,177
Metadata
- Authors
- Enlimomab Acute Stroke Trial Investigators
- Venue
- Neurology
- Published
- 2001-10-23
- Volume
- 57
- Issue
- 8
- Pages
- 1428-1434
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1773516416
- Cited by
- 544
- References
- 19
- FWCI
- 15.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.